NDN and Prader-Willi syndrome: Given that Necdin is essential for HSC quiescence and some patients with Prader-Willi syndrome develop AML [20–21, 29], we hypothesized that Necdin deficiency will stimulate quiescent LICs to enter the cell cycle and sensitize them to chemotherapy and improve leukemia treatment.